CD11R3 抗体 (FITC)
The FITC-conjugated 小鼠 单克隆 anti-CD11R3 antibody (Clone 2F4-11) (ABIN1819791) specifically detects CD11R3 in FACS, IHC, IP, WB 和 IHC (fro).
The antibody is reactive with Pig samples.
产品编号 ABIN1819791
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for CD11R3 抗体 (FITC) (ABIN1819791)
抗原
CD11R3
适用
Pig
宿主
小鼠
克隆类型
单克隆
标记
This CD11R3 antibody is conjugated to FITC
应用范围
Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
克隆位点
2F4-11
-
-
特异性
- Recognizes porcine CD11R3, a 155kD cell surface marker which is a member of the alpha integrin family. CD11R3 has a similar expression pattern to the human CD11b marker, being expressed on granulocytes, monocytes and alveolar macrophages, but not on lymphocytes, eythrocytes or platelets. Clone 2F4/11 is reported to block phagocytosis of complement-opsonized zymosan particles by polymononuclear granulocytes and alveolar macrophages. Removal of sodium azide is recommended prior to use in functional assays -.
-
纯化方法
- Protein G purified
-
免疫原
-
Porcine alveolar macrophages.
Type of Immunogen: Cells -
亚型
- IgG1
-
-
-
-
应用备注
-
Approved: Flo (1:1 - 1:10), IHC, IHC-Fr, IP, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
说明
-
Target Species of Antibody: Pig
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- PBS, 0.09 % sodium azide, 1 % BSA
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freezing and thawing. Protect from light.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short term: store at 4°C. Long term: -20°C. Avoid freeze-thaw cycles. Protect from light.
-
-
- CD11R3
-
别名
- CD11R3
抗原
-
You are here:
